BSC
AZN icon

BOLTON SECURITIES CORPORATION’s AstraZeneca AZN Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.24M Buy
+6,382
New +$1.23M 0.06% 332
2025
Q3 		$960K Buy
+6,260
New +$947K 0.05% 371
2025
Q1 		$790K Buy
+5,373
New +$777K 0.05% 381

Other funds holding AZN

Investor AB
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $148B AUM

BOLTON SECURITIES CORPORATION's AZN Position: Q1 2026 in Review

BOLTON SECURITIES CORPORATION opened a new position in AstraZeneca (AZN) in Q1 2026: 6,382 shares worth $1.24M. The stake represents 0.06% of the portfolio and ranks #332 among its holdings. This is a return to the name: BOLTON SECURITIES CORPORATION previously reported a position in AZN as recently as Q3 2025.

BOLTON SECURITIES CORPORATION first reported a position in AZN in Q1 2025 and has held it in 3 quarters since. 1,391 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • BOLTON SECURITIES CORPORATION held 6,382 shares of AstraZeneca worth $1.24M as of Q1 2026.
  • AstraZeneca was a new BOLTON SECURITIES CORPORATION position in Q1 2026.
  • AstraZeneca made up 0.06% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2026, its #332 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in AstraZeneca in Q1 2025 and has held it in 3 quarters since.
  • 1,391 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2026, filed 12 Nov 2026.